Fareon Open Label Device Clinical Trial
Fareon Open Label Device Clinical Trial
Not yet recruiting · NCT07600320 · Registry updated 2026-05-20Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Fareon Open Label Device Clinical Trial | Alzheimer disease, Brain Injuries, Traumatic, COVID-19, Chronic Disease, Cognition Disorders, Cognitive Dysfunction, Coronaviridae Infections, Craniocerebral Trauma, Disease Attributes, Infections, Neuroinflammatory Diseases, Nidovirales infectious disease, Orthocoronavirinae infectious disease, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Post-Infectious Disorders, RNA Virus Infections, brain disorder, brain injury, central nervous system disorder, cognitive disorder, dementia, encephalomyelitis, injury, long COVID-19, lung disorder, muscle tissue disorder, musculoskeletal system disorder, myalgic encephalomeyelitis/chronic fatigue syndrome, nervous system disorder, nervous system injury, neurodegenerative disease, neuromuscular disease, pneumonia, psychiatric disorder, respiratory system disorder, respiratory tract infectious disorder, tauopathy, viral infectious disease, viral pneumonia | Not yet recruiting | Not applicable | 2026-05-20 | NCT07600320 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Icahn School of Medicine at Mount Sinai | 256 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| The Cohen Center for Recovery from Complex Chronic Illnesses (CoRE) | New York | United States | 5 |